Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04506970 · ClinicalTrials.gov registry record

Predicting Placental Pathologies by Ultrasound Imaging

A clinical trial, sponsored by Mayo Clinic.

Completed
Registry status
60
Enrollment target

NCT04506970: Completed study, sponsored by Mayo Clinic.

NCT04506970 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04506970 has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
60 participants
Enrollment target

Study Summary

Intrauterine growth restriction (IUGR) is caused when the placenta cannot provide enough nutrients to allow normal growth of the fetus during pregnancy. It is unclear why IUGR happens, but an increase in inflammatory T cells in the placenta known as villitis of unknown etiology (VUE) is observed in many IUGR infants. The investigators aim to develop ultrasound methods for diagnosing VUE to understand it's role in IUGR.

Primary Outcome

Measured by Doppler and 3D microvessel imaging, used to calculate outcomes 3-5

Interventions

  • DIAGNOSTIC_TEST Comprehensive Doppler Ultrasound of the Placenta
  • OTHER Verasonics Ultrasound scanner (ultra-sensitive Doppler imaging)

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2020-09-27
Est. Completion 2023-10-31
Mayo Clinic

2,844 total trials

What the finished NCT04506970 record still lists

NCT04506970 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.

The record links to 0 conditions, and to 2 interventions - of which Comprehensive Doppler Ultrasound of the Placenta is the first listed.

NCT04506970 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04506970 about?

NCT04506970 is a clinical study titled "Predicting Placental Pathologies by Ultrasound Imaging". Intrauterine growth restriction (IUGR) is caused when the placenta cannot provide enough nutrients to allow normal growth of the fetus during pregnancy. It is unclear why IUGR happens, but an increase in inflammatory T cells in the placenta known as villitis of unknown etiology (VUE) is observed in ...

What is the current status of trial NCT04506970?

This trial is currently completed. The enrollment target is 60 participants. The study started on 2020-09-27. Estimated completion is 2023-10-31.

What interventions are being tested in trial NCT04506970?

The interventions under investigation include: Comprehensive Doppler Ultrasound of the Placenta (DIAGNOSTIC_TEST), Verasonics Ultrasound scanner (ultra-sensitive Doppler imaging) (OTHER).

Who is sponsoring clinical trial NCT04506970?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Learn More About Clinical Trials

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04506970, the US trial registry maintained by the National Library of Medicine. NCT04506970 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.